{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:10:03Z","timestamp":1785769803486,"version":"3.56.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"abstract":"<jats:sec>\n                    <jats:title>\u00a0<\/jats:title>\n                    <jats:p>\n                      This study aimed to evaluate the prognostic utility of serum carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) and CEACAM8 levels in children with\n                      <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (MPP). This single-center prospective cohort study enrolled 364 children with confirmed MPP and 160 age-matched healthy controls between February 2023 and May 2025. Serum levels of CEACAM6, CEACAM8, lactate dehydrogenase (LDH), D-dimer, interleukin-6, C-reactive protein, and myeloperoxidase were measured at admission using enzyme-linked immunosorbent assay. Patients were classified into good- (n\u2005=\u2005295) or poor-prognosis (n\u2005=\u200569) groups after 1 week of standardized azithromycin therapy based on clinical, radiological, and spirometric criteria. Multivariable logistic regression was used to identify independent predictors of poor outcome. Receiver-operating characteristic curve analysis assessed the predictive performance of CEACAM6 and CEACAM8, individually and in combination, with corresponding areas under the curve. Correlations with inflammatory markers were evaluated using the Spearman rank correlation test. Children with poor outcomes had significantly higher CEACAM6 and CEACAM8 levels at admission (both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Multivariable analysis identified elevated CEACAM6 (odds ratio\u2005=\u20051.12, 95% confidence interval\u2005=\u20051.05\u20131.19) and CEACAM8 (odds ratio\u2005=\u20051.09, 95% confidence interval\u2005=\u20051.03\u20131.15) as independent predictors of poor prognosis. Receiver-operating characteristic analysis demonstrated areas under the curve of 0.771 for CEACAM6, 0.755 for CEACAM8, and 0.826 for their combination. Both biomarkers correlated positively with interleukin-6, C-reactive protein, and myeloperoxidase (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01) and declined significantly after treatment. Serum CEACAM6 and CEACAM8 are independently associated with poor outcomes in pediatric MPP. Their combined use enhances prognostic accuracy and may support early risk stratification in clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048137","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:00:47Z","timestamp":1775840447000},"page":"e48137","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serum CEACAM6 and CEACAM8 as predictors of poor outcome in pediatric Mycoplasma pneumoniae pneumonia: A single-center prospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Shenghua","family":"Ge","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Shijiazhuang People\u2019s Hospital, Shijiazhuang, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0030-0222","authenticated-orcid":false,"given":"Lingyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Shijiazhuang People\u2019s Hospital, Shijiazhuang, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Shijiazhuang People\u2019s Hospital, Shijiazhuang, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260410","doi-asserted-by":"crossref","first-page":"28306","DOI":"10.1038\/s41598-025-13555-6","article-title":"Assessment of serum parameters caused by the outbreak of Mycoplasma pneumoniae pneumonia in children after COVID-19.","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13052-025-02137-x","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese children: a retrospective study of clinical features and prognosis.","volume":"51","author":"Zheng","year":"2025","journal-title":"Ital J Pediatr"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"1604102","DOI":"10.3389\/fcimb.2025.1604102","article-title":"Atelectasis predicts poor prognosis in pediatric macrolides-unresponsive Mycoplasma pneumoniae pneumonia with A2063\/2064G mutations treated with azithromycin.","volume":"15","author":"Cheng","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"20241114","DOI":"10.1515\/med-2024-1114","article-title":"Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia.","volume":"20","author":"Zhao","year":"2025","journal-title":"Open Med (Wars)"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"1585042","DOI":"10.3389\/fpubh.2025.1585042","article-title":"Building a diagnostic prediction model for severe Mycoplasma pneumoniae pneumonia in children using machine learning.","volume":"13","author":"Gong","year":"2025","journal-title":"Front Public Health"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"1552144","DOI":"10.3389\/fcimb.2025.1552144","article-title":"Biomarkers associated with the diagnosis and prognosis of Mycoplasma pneumoniae pneumonia in children: a review.","volume":"15","author":"Ding","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"1388453","DOI":"10.3389\/fimmu.2024.1388453","article-title":"Editorial: role of carcinoembryonic antigen-related cell adhesion molecules in pathogen responses, tumorigenicity, and immune modulation.","volume":"15","author":"Khairnar","year":"2024","journal-title":"Front Immunol"},{"key":"R8-20260410","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3892\/ijo.2024.5615","article-title":"The emerging roles of CEACAM6 in human cancer (Review).","volume":"64","author":"Wu","year":"2024","journal-title":"Int J Oncol"},{"key":"R9-20260410","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12672-024-01053-6","article-title":"CEACAM6 expression and function in tumor biology: a comprehensive review.","volume":"15","author":"Zhao","year":"2024","journal-title":"Discov Oncol"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1164\/rccm.202208-1603OC","article-title":"CEACAM6 as a novel therapeutic target to boost HO-1-mediated antioxidant defense in COPD.","volume":"207","author":"Wu","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"e94106","DOI":"10.1371\/journal.pone.0094106","article-title":"Soluble CEACAM8 interacts with CEACAM1 inhibiting TLR2-triggered immune responses.","volume":"9","author":"Singer","year":"2014","journal-title":"PLoS One"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12026-025-09626-5","article-title":"Study of immunological and inflammatory gene response in Indian cohort of COVID-19 patients by nanostring technology.","volume":"73","author":"Sundarrajan","year":"2025","journal-title":"Immunol Res"},{"key":"R13-20260410","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.21037\/tp-2025-296","article-title":"Predictive value of CCL26 and CCR3 levels for prognosis assessment in children with Mycoplasma pneumoniae pneumonia treated with azithromycin.","volume":"14","author":"Ma","year":"2025","journal-title":"Transl Pediatr"},{"key":"R14-20260410","first-page":"1","article-title":"Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023).","volume":"9","year":"2025","journal-title":"Pediatr Investig"},{"key":"R15-20260410","first-page":"592","article-title":"The clinical pulmonary infection score combined with procalcitonin and lung ultrasound (CPIS-PLUS), a good tool for ventilator associated pneumonia early diagnosis in pediatrics.","volume":"11","author":"Becerra-Herv\u00e1s","year":"2024","journal-title":"Children (Basel)"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"1565773","DOI":"10.3389\/fped.2025.1565773","article-title":"Risk analysis of poor prognosis and follow-up observation of children with Mycoplasma pneumoniae pneumonia complicated by plastic bronchitis.","volume":"13","author":"Zheng","year":"2025","journal-title":"Front Pediatr"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.2147\/JIR.S561489","article-title":"Predictive value of traditional and novel composite inflammatory indicators for severe and refractory Mycoplasma pneumoniae pneumonia in children.","volume":"18","author":"Fan","year":"2025","journal-title":"J Inflamm Res"},{"key":"R18-20260410","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41598-021-81853-w","article-title":"The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory Mycoplasma pneumoniae pneumonia in children.","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"R19-20260410","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13052-025-02064-x","article-title":"Shifting epidemic trends and severity in pediatric Mycoplasma pneumoniae infections in the post-COVID-19 era.","volume":"51","author":"Yang","year":"2025","journal-title":"Ital J Pediatr"},{"key":"R20-20260410","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3390\/antiox11112302","article-title":"Myeloperoxidase: regulation of neutrophil function and target for therapy.","volume":"11","author":"Rizo-T\u00e9llez","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"R21-20260410","doi-asserted-by":"crossref","first-page":"1189647","DOI":"10.3389\/fimmu.2023.1189647","article-title":"Immune response plays a role in Mycoplasma pneumoniae pneumonia.","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"R22-20260410","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s13104-025-07334-9","article-title":"Neutrophil extracellular traps as a predictive biomarker for severe Mycoplasma pneumonia in children: a clinical observational study.","volume":"18","author":"Fan","year":"2025","journal-title":"BMC Res Notes"},{"key":"R23-20260410","doi-asserted-by":"crossref","first-page":"e14349","DOI":"10.1111\/eci.14349","article-title":"The role of CEACAMs in neutrophil function.","volume":"54","author":"Skubitz","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"R24-20260410","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-021-03661-y","article-title":"The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","volume":"25","author":"Huang","year":"2021","journal-title":"Crit Care"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"105647","DOI":"10.1016\/j.micpath.2022.105647","article-title":"Cell damage and neutrophils promote the infection of Mycoplasma pneumoniae and inflammatory response.","volume":"169","author":"Zhang","year":"2022","journal-title":"Microb Pathog"},{"key":"R26-20260410","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12931-025-03167-z","article-title":"Neutrophils are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma pneumoniae pneumonia.","volume":"26","author":"Huang","year":"2025","journal-title":"Respir Res"},{"key":"R27-20260410","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1002\/iid3.70168","article-title":"Serum lactate dehydrogenase levels reflect the lung injury extension in COVID-19 patients at hospital admission.","volume":"13","author":"Bertilacchi","year":"2025","journal-title":"Immun Inflamm Dis"},{"key":"R28-20260410","doi-asserted-by":"crossref","first-page":"e0162624","DOI":"10.1128\/spectrum.01626-24","article-title":"C-reactive protein-induced injury in Mycoplasma pneumoniae-infected lung epithelial cells is mediated by the P38 MAPK\/mitochondrial apoptosis pathway.","volume":"13","author":"Li","year":"2025","journal-title":"Microbiol Spectr"},{"key":"R29-20260410","doi-asserted-by":"crossref","first-page":"1480844","DOI":"10.3389\/fphar.2025.1480844","article-title":"The role and impact of the IL-6 mediated JAK2-STAT1\/3 signaling pathway in the pathogenesis of gout.","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Pharmacol"},{"key":"R30-20260410","doi-asserted-by":"crossref","first-page":"e44999","DOI":"10.1097\/MD.0000000000044999","article-title":"Threshold effect of white blood cell count on the risk of refractory Mycoplasma pneumoniae pneumonia in pediatric patients: a retrospective cohort study.","volume":"104","author":"Liu","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"R31-20260410","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/antiox13010132","article-title":"The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress.","volume":"13","author":"Lin","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"R32-20260410","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.12688\/f1000research.126721.1","article-title":"Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker.","volume":"11","author":"Rinchai","year":"2022","journal-title":"F1000Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:21:46Z","timestamp":1785766906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":32,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048137","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"2025-11-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}